Companies / Regentis Biomaterials
Regentis Biomaterials
Israel
Regentis Biomaterials is a tissue repair company focused on developing and commercializing an innovative hydrogel platform for the repair of damaged tissue.
Regentis Biomaterials, based in Israel, has 1 investor on file, among them SCP Vitalife Partners. Its latest round on record is Series A, 17 Jun 2026. Its site was last checked 13 Nov 2026: site answers.
Funding
1 round on recordRound sizes and total raised are on Fundup AI, our sister product for funding data.
Investors
1 investor on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital |
More from SCP Vitalife Partners
6 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (100%).
See SCP Vitalife Partners' full profile · Who invests alongside it
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Regentis Biomaterials and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when SCP Vitalife Partners adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/regentis.co.il/investors
# also
GET /v1/companies/regentis.co.il
GET /v1/companies/regentis.co.il/news